BIT: FF Statistics

Total Valuation

Fine Foods & Pharmaceuticals N.T.M. has a market cap or net worth of EUR 176.76 million. The enterprise value is 224.47 million.

Market Cap	176.76M
Enterprise Value	224.47M

Important Dates

The next estimated earnings date is Tuesday, April 1, 2025.

Earnings Date	Apr 1, 2025
Ex-Dividend Date	Jun 3, 2024

Share Statistics

Fine Foods & Pharmaceuticals N.T.M. has 24.48 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	24.48M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.76%
Float	10.89M

Valuation Ratios

The trailing PE ratio is 36.43 and the forward PE ratio is 15.57.

PE Ratio	36.43
Forward PE	15.57
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.50
P/FCF Ratio	14.26
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.17, with an EV/FCF ratio of 18.11.

EV / Earnings	46.26
EV / Sales	0.92
EV / EBITDA	7.17
EV / EBIT	14.74
EV / FCF	18.11

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.43.

Current Ratio	1.47
Quick Ratio	0.68
Debt / Equity	0.43
Debt / EBITDA	1.81
Debt / FCF	4.58
Interest Coverage	3.76

Financial Efficiency

Return on equity (ROE) is 3.74% and return on invested capital (ROIC) is 4.59%.

Return on Equity (ROE)	3.74%
Return on Assets (ROA)	3.77%
Return on Capital (ROIC)	4.59%
Revenue Per Employee	323,177
Profits Per Employee	6,443
Employee Count	753
Asset Turnover	0.96
Inventory Turnover	3.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.90% in the last 52 weeks. The beta is 0.68, so Fine Foods & Pharmaceuticals N.T.M.'s price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-17.90%
50-Day Moving Average	7.79
200-Day Moving Average	8.40
Relative Strength Index (RSI)	35.50
Average Volume (20 Days)	5,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fine Foods & Pharmaceuticals N.T.M. had revenue of EUR 243.35 million and earned 4.85 million in profits.

Revenue	243.35M
Gross Profit	75.80M
Operating Income	15.23M
Pretax Income	6.92M
Net Income	4.85M
EBITDA	30.60M
EBIT	15.23M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 9.06 million in cash and 56.76 million in debt, giving a net cash position of -47.70 million or -1.95 per share.

Cash & Cash Equivalents	9.06M
Total Debt	56.76M
Net Cash	-47.70M
Net Cash Per Share	-1.95
Equity (Book Value)	130.55M
Book Value Per Share	n/a
Working Capital	29.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 41.79 million and capital expenditures -29.40 million, giving a free cash flow of 12.40 million.

Operating Cash Flow	41.79M
Capital Expenditures	-29.40M
Free Cash Flow	12.40M
FCF Per Share	0.51

Full Cash Flow Statement

Margins

Gross margin is 31.15%, with operating and profit margins of 6.26% and 1.99%.

Gross Margin	31.15%
Operating Margin	6.26%
Pretax Margin	2.84%
Profit Margin	1.99%
EBITDA Margin	12.57%
EBIT Margin	6.26%
FCF Margin	5.09%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.66%.

Dividend Per Share	0.12
Dividend Yield	1.66%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	60.55%
Buyback Yield	n/a
Shareholder Yield	1.66%
Earnings Yield	n/a
FCF Yield	7.01%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Fine Foods & Pharmaceuticals N.T.M. has an Altman Z-Score of 2.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.74
Piotroski F-Score	n/a